✦ LIBER ✦

PCV20 A COST-EFFECTIVENESS ANALYSIS OF STATIN THERAPY IN A MANAGED CARE POPULATION

✍ Scribed by MF Bullano; VJ Willey; MJ Cziraky; L Graham; JC Corbelli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV50 STATIN THERAPY PERSISTENCE IN A MA

✍ SM Wang; W Yang; MB Nichol; T Dow; KA Johnson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCV89 COMPARISON OF DOSING PATTERNS AMON

✍ Z. Zhao; X. Peng; J.P. Bae; J. Dungey; D.E. Faries; C.A. Sponseller; S. Wetmore; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV60 MEDICATION ADHERENCE, PERSISTENCE,

✍ Z. Zhao; X. Peng; J.P. Bae; J. Dungey; D.E. Faries; C.A. Sponseller; S. Wetmore; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV21 PREVALENCE AND COST IMPLICATIONS O

✍ LR Etemad; C Fairchild; R Waldeck 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

PCV42 INCREMENTAL COST-EFFECTIVENESS ANA

✍ LA Miller; R Wade; MJ Cziraky; D Dai; K Mayo; K Ramsawany 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PCV42 PERSISTENCE AND ADHERENCE TO STATI

✍ C Quach; MB Nichol; L Chen; BV Patel; D Berenbeim 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB